Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Jun;93(6):605-9.
doi: 10.1111/j.1349-7006.2002.tb01297.x.

Promoter methylation of TSLC1 and tumor suppression by its gene product in human prostate cancer

Hiroshi Fukuhara  1 , Masami Kuramochi, Takeshi Fukami, Kohtaro Kasahara, Mutsuo Furuhata, Takahiro Nobukuni, Tomoko Maruyama, Kana Isogai, Takao Sekiya, Taro Shuin, Tadaichi Kitamura, Roger H Reeves, Yoshinori Murakami
Affiliations

Promoter methylation of TSLC1 and tumor suppression by its gene product in human prostate cancer

Hiroshi Fukuhara et al. Jpn J Cancer Res. 2002 Jun.

Abstract

We recently identified TSLC1, a tumor suppressor gene in human lung cancer. Gene silencing by promoter methylation has been observed frequently in adenocarcinoma of the lung, liver, and pancreas. Here, we demonstrate that TSLC1 expression is also absent or markedly reduced in 3 of 4 prostate cancer cell lines. Promoter sequences of TSLC1 were heavily methylated in PPC-1 cells that lacked TSLC1 expression, supporting the idea that promoter methylation is strongly correlated with complete loss of gene expression. Promoter sequences of TSLC1 were also methylated significantly in 7 of 22 (32%) primary prostate cancers. Hypermethylation of the promoter occurred not only in advanced tumors, but also in relatively early-stage tumors. Restoration of TSLC1 expression substantially suppressed tumor formation of PPC-1 cells in nude mice. These findings indicate that alteration of TSLC1 is involved in prostate cancer.

PubMed Disclaimer

References

    1. ) Parker , S. L. , Tong , T. , Bolden , S. and Wingo , P. A.Cancer Statistics , 47 , 5 – 27 ( 1997. ). - PubMed
    1. ) Kakizoe , T.Figures on cancer in Japan—1997 . Foundation for Promotion of Cancer Research ( 1999. ).
    1. ) Ozen , M. and Pathak , S.Genetic alterations in human prostate cancer: a review of current literature . Anticancer Res. , 20 ( 3B ), 1905 – 1912 ( 2000. ). - PubMed
    1. ) Murakami , Y. , Nobukuni , T. , Tamura , K. , Maruyama , T. , Sekiya , T. , Arai , Y. , Gomyou , H. , Tanigami , A. , Ohki , M. , Cabin , D. , Frischmeyer , P. , Hunt , P. and Reeves , R. H.Localization of tumor suppressor activity important in non‐small cell lung carcinoma on chromosome 11q . Proc. Natl. Acad. Sci. USA , 95 , 8153 – 8158 ( 1998. ). - PMC - PubMed
    1. ) Kuramochi , M. , Fukuhara , H. , Nobukuni , T. , Kanbe , T. , Maruyama , T. , Ghosh , H. P. , Pletcher , M. , Isomura , M. , Onizuka , M. , Kitamura , M. , Sekiya , T. , Reeves , R. H. and Murakami , Y.TSLC1 is a tumor suppressor gene in human non‐small cell lung cancer . Nat. Genet. , 27 , 427 – 430 ( 2001. ). - PubMed

Publication types

MeSH terms

LinkOut - more resources